Skip to main content
    N

    NanoVibronix Inc (NAOV)

    Official site

    MEDICAL DEVICES

    $4.31
    -0.43 (-9.07%)

    Last updated: Dec 10, 2025 at 4:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    43%(3/7)
    Avg Surprise
    -46.16%
    Streak
    3 Q
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 18
    $-0.91N/AN/ABeat-155.2%
    Jun 25
    Reported Aug 19
    $-1.03N/AN/ABeat-316.8%
    Mar 25
    Reported May 20
    $-39.85N/AN/ABeat-16915.4%
    Dec 24
    Reported Mar 31
    $-4.21N/AN/ABeat+90.4%
    Sep 24
    Reported Nov 14
    $-0.36N/AN/ABeat+15.7%
    Jun 24
    Reported Aug 14
    $-0.25N/AN/ABeat+61.8%
    Mar 24
    Reported Apr 8
    $-0.23N/AN/ABeat+64.7%
    Dec 23
    Reported Feb 28
    $-43.70N/AN/ABeat-1038.1%
    Sep 23
    Reported Nov 13
    $-0.42N/AN/ABeat-1138.7%
    Jun 23
    Reported Aug 11
    $-0.65N/AN/ABeat-1192.2%
    Mar 23
    Reported Apr 17
    $-0.66N/AN/ABeat-453.4%
    Dec 22
    Reported Mar 1
    $-3.84$0.00N/AMiss-3100.0%
    Sep 22
    Reported Nov 14
    $-0.03N/AN/ABeat+71.6%
    Jun 22
    Reported Aug 15
    $-0.05N/AN/ABeat+58.3%
    Mar 22
    Reported Apr 5
    $-0.12N/AN/ABeat+0.0%
    Dec 21
    Reported Mar 2
    $-0.12N/AN/ABeat-100.0%
    Sep 21
    Reported Nov 16
    $-0.12N/AN/ABeat-20.0%
    Jun 21
    Reported Aug 16
    $-0.12N/AN/ABeat+64.7%
    Mar 21
    Reported Apr 15
    $-0.12N/AN/ABeat+0.0%
    Dec 20
    Reported Mar 3
    $-0.06N/AN/ABeat+50.0%
    Sep 20
    Reported Nov 16
    $-0.10N/AN/ABeat+95.8%
    Jun 20
    Reported Jul 6
    $-0.34N/AN/ABeat+89.4%
    Mar 20
    Reported May 20
    $-0.12$0.00N/ABeat+98.5%
    Dec 19
    Reported Feb 26
    $-0.12$-0.20+40.00%Beat+33.3%
    Sep 19
    Reported Nov 19
    $-2.40$-4.00+40.00%Beat-1042.9%
    Jun 19
    Reported Aug 14
    $-3.20$-4.00+20.00%Beat-814.3%
    Mar 19
    Reported Apr 15
    $-8.00$-3.20-150.00%Miss-2185.7%
    Dec 18
    Reported Feb 27
    $-0.18$-0.16-12.50%Miss+48.6%
    Sep 18
    Reported Nov 14
    $-0.21N/AN/ABeat+40.0%
    Jun 18
    Reported Aug 14
    $-0.35N/AN/ABeat-84.2%
    Mar 18
    Reported May 15
    $-0.35N/AN/ABeat+5.4%
    Dec 17
    Reported Mar 29
    $-0.35N/AN/ABeat+93.0%
    Sep 17
    Reported Nov 14
    $-0.35$-0.15-133.33%Miss-
    Jun 17
    Reported Jul 26
    $-0.19$0.00N/ABeat-
    Mar 17
    Reported May 15
    $-0.37$0.00N/ABeat-
    Dec 16
    Reported Mar 31
    $-5.00$-2.20-127.27%Miss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.19
    SMA 20$4.26
    SMA 50$5.16
    SMA 200N/A
    EMA 10$4.30
    EMA 20$4.39
    EMA 50$5.19
    EMA 200$21.87

    MACD

    Line: -0.21Signal: -0.32Hist: 0.11

    ADX

    ADX: 16.3+DI: 27.4-DI: 16.8

    Aroon & PSAR

    Aroon Up60.0
    Aroon Down52.0
    PSAR$3.88

    Bollinger Bands

    Upper Band$4.96
    Lower Band$3.55
    %B Position3301%(Upper)
    Band Width0.54

    RSI (14-Day)

    Neutral
    46.6

    Momentum Oscillators

    Stoch %K52.3
    Stoch %D46.3
    Williams %R-58.0
    ROC (10d)-13.5%
    Momentum-0.67
    CCI (20d)24.0
    MFI (14d)66.7

    Volatility Measures

    ATR (14d)$0.45(10.4%)
    StdDev (20d)0.35
    Hist Vol127.0%(High)

    Volume Flow

    VWAP$4.35
    OBV209.5M
    AD Line27.9B
    CMF (20d)0.155

    Volume Metrics

    Avg Vol (20d)31.3K
    Vol Ratio0.6x
    VWMA (20d)$4.42

    Pivot Points

    R3$5.30
    R2$5.02
    R1$4.88
    Pivot Point$4.60
    S1$4.46
    S2$4.18
    S3$4.04

    Advanced Oscillators

    TSI-13.11
    Ultimate Osc55.0
    KST-193.82

    Financial Data

    QuarterSep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Total Revenue$722,000$494,000$1.02M$444,000$376,000$817,000$921,000$1.18M$458,000$294,000$354,000$-102,000
    Cost of RevenueN/A$529,000$656,000$161,000$243,000$389,000$257,000$440,000$109,000$78,000$119,000$198,000
    Gross ProfitN/A$-35,000$369,000$283,000$133,000$428,000$664,000$737,000$349,000$216,000$235,000$-300,000
    Operating ExpensesN/A$3.94M$2.22M$1.65M$1.10M$1.10M$1.23M$1.88M$1.02M$1.23M$1.29M$1.61M
    R&D$0$972,000$530,000$352,000$249,000$187,000$121,000$62,000$33,000$35,000$55,000$107,000
    SG&A$0$2.25M$1.34M$1.13M$673,000$716,000$946,000$1.38M$796,000$963,000$1.02M$1.30M
    Operating IncomeN/A$-3,976,000$-1,852,000$-1,370,000$-970,000$-674,000$-568,000$-702,000$-670,000$-1,009,000$-1,055,000$-1,708,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$144,000$63,000$34,000$33,000$34,000$13,000$33,000$54,000$33,000$34,000$300,000
    Income Before Tax$0$-3,909,000$-2,480,000$-1,426,000$-995,000$-684,000$-581,000$-802,000$-724,000$-1,061,000$-1,095,000$-2,062,000
    Income Tax Expense$0$62,000$15,000$5,000$3,000$4,000$-7,000$0$-3,000$13,000$2,000$-3,000
    Net Income$510,000$-156,000$-2,495,000$-1,431,000$-998,000$-688,000$-588,000$-813,000$-727,000$-1,074,000$-1,097,000$-2,059,000
    EBITDA$767,000$-3,401,000$-2,409,000$-1,392,000$-970,000$-673,000$-567,750N/A$-670,000$-1,009,000$-1,055,000$-1,762,000
    EBIT$510,000$-3,765,000$-2,427,000$-1,370,000N/A$-674,000$-568,000N/A$-630,414$-990,000$-1,056,000$-1,451,092
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NAOV

    News

    No news available

    Company news will appear here when available

    NAOV Bull Case vs Bear Case

    Bear case

    • NAOV beat EPS estimates in 37.5% of its last 8 reported quarters.

    NAOV Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -32.6%

    Frequently Asked Questions About NAOV

    Does NAOV pay dividends?

    NanoVibronix Inc (NAOV) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.